Sun, D., Hou, H., Feng, F., Wu, W., Tan, J., Xie, T., . . . Xing, P. A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma. BMC.
Chicago Style (17th ed.) CitationSun, Dantong, et al. A Cohort-based Multi-omics Identifies Nuclear Translocation of EIF5B /PD-L1/CD44 Complex as the Target to Overcome Osimertinib Resistance of ARID1A-deficient Lung Adenocarcinoma. BMC.
MLA (9th ed.) CitationSun, Dantong, et al. A Cohort-based Multi-omics Identifies Nuclear Translocation of EIF5B /PD-L1/CD44 Complex as the Target to Overcome Osimertinib Resistance of ARID1A-deficient Lung Adenocarcinoma. BMC.
Warning: These citations may not always be 100% accurate.